Treatment of psoriasis with calcipotriol and other vitamin D analogues

This publication has 41 references indexed in Scilit:

• Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
  Journal of the American Academy of Dermatology, 1992
• Contact dermatitis from MC 903, a topical vitamin D₃ analogue
  Contact Dermatitis, 1991
• 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production
  Biochemical and Biophysical Research Communications, 1991
• Agonist/Inosital Trisphosphate-Induced Release of Calcium from Murine Keratinocytes: A Possible Link with Keratinocyte Differentiation
  Journal of Investigative Dermatology, 1991
• DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 nalogue MC903 and betamethasone
  British Journal of Dermatology, 1990
• Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium
  Biochemical and Biophysical Research Communications, 1990
• Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens
  British Journal of Dermatology, 1989
• Epidermal Keratin Levels during Oral 1-Alpha-Hydroxyvitamin D3 Treatment for Psoriasis
  Skin Pharmacology and Physiology, 1989
• A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis
  Journal of the American Academy of Dermatology, 1988
• Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
  British Journal of Dermatology, 1988